Regen BioPharma, Inc.
RGBP · OTC
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $422 | $6,384 | $15,304 | $45,903 |
| - Cash | $1 | $121 | $51 | $727 |
| + Debt | $815 | $756 | $1,274 | $3,583 |
| Enterprise Value | $1,236 | $7,019 | $16,527 | $48,759 |
| Revenue | $237 | $237 | $236 | $171 |
| % Growth | 0% | 0.4% | 37.6% | – |
| Gross Profit | $237 | $237 | $186 | $146 |
| % Margin | 100% | 100% | 78.8% | 85.4% |
| EBITDA | -$418 | $3,119 | $2,993 | -$6,197 |
| % Margin | -176.7% | 1,318.5% | 1,270.8% | -3,620% |
| Net Income | -$668 | $1,024 | $2,227 | -$6,765 |
| % Margin | -282.4% | 432.9% | 945.6% | -3,951.7% |
| EPS Diluted | -0.16 | 0.14 | 0.36 | -1.69 |
| % Growth | -214.3% | -61.1% | 121.3% | – |
| Operating Cash Flow | -$693 | -$174 | -$607 | -$1,131 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$693 | -$174 | -$607 | -$1,131 |